111 related articles for article (PubMed ID: 2565605)
1. Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors.
Fox E; Widemann BC; Pastakia D; Chen CC; Yang SX; Cole D; Balis FM
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1273-83. PubMed ID: 26486517
[TBL] [Abstract][Full Text] [Related]
2. Improvement of tumor targeting and antitumor activity by a disulphide bond stabilized diabody expressed in Escherichia coli.
Liu J; Yang M; Wang J; Xu Y; Wang Y; Shao X; Yang C; Gao Y; Xiong D
Cancer Immunol Immunother; 2009 Nov; 58(11):1761-9. PubMed ID: 19259665
[TBL] [Abstract][Full Text] [Related]
3. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
Hu XF; Slater A; Rischin D; Kantharidis P; Parkin JD; Zalcberg J
Br J Cancer; 1999 Feb; 79(5-6):831-7. PubMed ID: 10070877
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic drug resistance in the management of head and neck cancer.
Bier H
Eur Arch Otorhinolaryngol; 1993; 250(4):200-8. PubMed ID: 8369114
[TBL] [Abstract][Full Text] [Related]
5. Modulation of tumor cell response to chemotherapy by the organ environment.
Fidler IJ; Wilmanns C; Staroselsky A; Radinsky R; Dong Z; Fan D
Cancer Metastasis Rev; 1994 Jun; 13(2):209-22. PubMed ID: 7923551
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta.
MacFarland A; Abramovich DR; Ewen SW; Pearson CK
Histochem J; 1994 May; 26(5):417-23. PubMed ID: 7913921
[TBL] [Abstract][Full Text] [Related]
7. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
[TBL] [Abstract][Full Text] [Related]
8. 5'-Deoxy-5-fluorouridine increases daunorubicin uptake in multidrug-resistant cells and its activity is related with P-gp 170 expression.
van der Heyden S; Gheuens E; van de Vrie W; Van Bockstaele D; Van Oosterom A; Eggermont A; De Bruijn EA
Jpn J Cancer Res; 1994 Jan; 85(1):13-6. PubMed ID: 7906263
[TBL] [Abstract][Full Text] [Related]
9. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.
Hu XF; Slater A; Wall DM; Kantharidis P; Parkin JD; Cowman A; Zalcberg JR
Br J Cancer; 1995 May; 71(5):931-6. PubMed ID: 7734315
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans.
Mross K; Mayer U; Hamm K; Burk K; Hossfeld DK
Eur J Clin Pharmacol; 1990; 39(5):507-13. PubMed ID: 2076745
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside salvage and resistance to antimetabolite anticancer agents.
Fox M; Boyle JM; Kinsella AR
Br J Cancer; 1991 Sep; 64(3):428-36. PubMed ID: 1911182
[No Abstract] [Full Text] [Related]
12. marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli.
Hächler H; Cohen SP; Levy SB
J Bacteriol; 1991 Sep; 173(17):5532-8. PubMed ID: 1715857
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma.
Axiotis CA; Monteagudo C; Merino MJ; LaPorte N; Neumann RD
Am J Pathol; 1991 Apr; 138(4):799-806. PubMed ID: 1707232
[TBL] [Abstract][Full Text] [Related]
14. Active efflux mechanisms for antimicrobial resistance.
Levy SB
Antimicrob Agents Chemother; 1992 Apr; 36(4):695-703. PubMed ID: 1503431
[No Abstract] [Full Text] [Related]
15. PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia.
Rochlitz CF; de Kant E; Neubauer A; Heide I; Böhmer R; Oertel J; Huhn D; Herrmann R
Ann Hematol; 1992 Dec; 65(6):241-6. PubMed ID: 1360821
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.
Cole SP; Pinkoski MJ; Bhardwaj G; Deeley RG
Br J Cancer; 1992 Apr; 65(4):498-502. PubMed ID: 1314068
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein and multidrug resistance in cancer chemotherapy.
Deuchars KL; Ling V
Semin Oncol; 1989 Apr; 16(2):156-65. PubMed ID: 2565605
[No Abstract] [Full Text] [Related]
18. Multidrug resistance: molecular biology and clinical relevance.
Rothenberg M; Ling V
J Natl Cancer Inst; 1989 Jun; 81(12):907-10. PubMed ID: 2567355
[No Abstract] [Full Text] [Related]
19. Multidrug resistance in human cancer.
Goldstein LJ; Pastan I; Gottesman MM
Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
